18Nov/13

Drug Shows Early Promise in Treating Liver Failure-Related Seizures – Drug Discovery & Development

Drug Shows Early Promise in Treating Liver Failure-Related Seizures
Drug Discovery & Development
A study in the journal Nature Medicine suggests a potential new treatment for the seizures that often plague children with genetic metabolic disorders and individuals undergoing liver failure. The discovery hinges on a new understanding of the complex 

and more »

18Nov/13

Spironolactone Reduces Heart Failure Hospitalizations, but Not Mortality … – Science Daily (press release)


Medscape

Spironolactone Reduces Heart Failure Hospitalizations, but Not Mortality
Science Daily (press release)
18, 2013 — A late-breaking clinical trial, known as the Treatment of Preserved Cardiac Function Heart Failure with an Aldosterone Antagonist (TOPCAT) trial, to be presented at the American Heart Association (AHA) Scientific Sessions, November 18, 2013
AHA: Decision on Spironolactone in HF a Toss-Up?MedPage Today
Aldo-Antagonist Falls Short but Impresses in Preserved-EF Heart Failure: TOPCATMedscape

all 7 news articles »